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i Summary: The use of reference method procedures in clinical chemical analysis is advocated by many experts
i äs the most reliable approach to obtaining accurate results. The performance of such procedures must,
however, be rigorous. This contribution will emphasize the importance of interlaboratory studies for this
purpose. Examples will be presented, taken from the work done under the BCR programme of the Commission
of the European Communities. The determination of steroid hormones in serum by isotope dilution mass
spectrometry and the measurement of enzyme catalytic activities, according to IFCC recommended methods,
will be discussed.
The Concept of Accuracy
One of the often quoted definitions for a reference
method is: "a method which after exhaustive investi-
gation has been shown to have negligible inaccuracy"
(l a). Büttner (Ib) earlier pointed out the imortance
of assessing accuracy. This contribution is intended
to draw attention to the difficulty of demonstrating
accuracy.
Before getting into complex measurernent processes,
such äs those involved in the field of clinical chemistry,
it seems appropriate to Start with an example taken
from the metrology field. At the top of the measure-
ment hierarchy stand the primary Metrology Insti-
tutes. Their role is to provide the means of calibration
for all base and derived quantities. Metrology Institutes
have developed quite an expertise in the identification
and quantification of measurement errors. The most
difficult task however is still the appraisal of the
systematic comppnent of the measurement error.
l) Based on a lecture given at the Symposium "Reference Meth-
ods in Clinical Chemistry — Objectives, Trends, Problems"
of the Congress Biochemische Analytik 90, München, May 8,
1990
The problem can be illustrated by the results of an
intercomparison of mass measurements organised by
the Community Bureau of Reference and involving
European Metrology Institutes (2). The purpose was
to measure a 50 g mass. The results were to be .ex-
pressed äs corrections to the nominal value of 50 g.
The results are shown in figure l together with the
calculated uncertainties (äs vertical bars). It should
be noted that in Metrology laboratories, the uncer-
tainties are derived from a combination of the vari-
ances of both random and systematic errors. Looking
at these results and in particular at the scale of the
plot, one first realizes that the between-laboratory
differences are extremely small. However one partic-
ipant (Lab 6) evidently had a problem that he did
not suspect, äs the uncertainty of the measurement
results was underestimated. This suggests that even
for a base quantity such äs a mass, and for well trained
laboratories the claim of absence of inaccuracy is a
risky Statement. If all the participating laboratories
were able to assess their inaccuracy, all the uncertainty
intervals äs established here would overlap each other.
In fact the intercomparison enabled the discrepancy
to be perceived by Lab 6. This and other examples
show that the search for the "true" value of a quantity
should preferably result from a comparison process.
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Fig. l. Results of an intercomparison for the measurement of
a 50 g mass, involving six Metrology Institutes. Results
are expressed äs deviations from the nominal 50 g value.
Bars represent the uncertainties calculated by the par-
ticipants, including random and systematic components.
Let us now consider the field of clinical chemistry
where considerable effort has been devoted to the
development of reference methods. One measurement
principle turrently presented äs a sound basis for a
reference method in many applications is that of iso-
tope dilution mass spectrometry (IDMS) (3). The
accuracy achievable by this measurement principle
must, however, be established, and this can only be
achieved in a reliable manner by interlaboratory stud-
ies.
Selected Examples
To exemplify the need for collaborative effort, the
results of a series of interlaboratory studies conducted
by the Community Bureau of Reference will be
shown.
The work done for the determination of progesterone
in serum is taken äs the first example. Six European
laboratories, all using an isotope dilution/mass spec-
trometry (IDMS) procedure, were involved. It is in-
teresting to show the progressive yet difficult improve-
ment achieved by this group of laboratories. Figure
2 shows the deviation of each laboratory mean from
the mean of the means of four consecutive trials. The
error bar Stands for the random component of the
error i.e. 2 Standard deviations of the laboratory
mean in each case. Each time, a different serum sam-
ple was analysed to assess to specificity of the pro-
cedure under test in each laboratory. The progester-
one concentration was similar in each of the four
serum samples and of the order of 10 nmol/1. Going
from the lyophilized serum sample assayed on the
first occasion to the liquid serum examined next, the
between-laboratory Variation increased, This wors-
ening led the participants to scrutinize their proce-
dures. The consequence of that investigation was that
on the following liquid sample the agreement between
-2
3 4
Laboratory code
Fig. 2. Results of a series of four intercomparisons for the
measurement of serum progesterone, involving six lab-
oratories using an isotope dilution/mass spectrometry
procedure. On each sample, and for each laboratory,
results are expressed äs the deviation of the laboratory
mean relative to the mean of all laboratories. In each
case, the error bar represents 2 SD of the laboratory
mean.
1985 lyophiiized
1986 liquid
1988 liquid
g§§ 1989 lyophilized
the results was noticeably better. Figure 3 presents
the overall improvement over the four year period in
terms of both between- and within-laboratory coef-
ficierits of Variation. Maybe it could be argued that
all the participants had not sufficiently validated their
procedures before starting. On the other band, each
of them could testify that it is only the confrontation
of the results that permitted unsuspected sources of
errors to be identified.
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Fig. 3. Results of four intercomparisons for the measurement
of serum progesterorie, involving six laboratories using
an isotope dilution/mass spectrometry procedure. Re-
sults are expressed in terms of both between- and within-
laboratory coefficients of Variation.
| Between laboratory Within laboratory
There comes a stage where no furthef improvement
can be made. This should be takeri äs an estimate of
the analytical state-of-the-art. Figure 4 shows the
results obtained by the six lafooratories on the last
lyophilized serum sample. The vertical bar again re-
presents 2 Standard deviations of the laboratory mean.
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Fig. 4. Results of the certification exercise for the measurement
of serum progesterone in CRM 347, involving six lab-
oratories using an Isotope dilution/mass spectrometry
procedure. For each laboratory, the results are expressed
s the laboratory mean value ± l SD.
It was suggested that such a realization of the meas-
ured quantity should be maintained and made avail-
able to help transfer the reference method value.
• Therefore the Community Bureau of Reference
i (BCR) was asked to issue Certified Reference Mate-
rials (CRM) with values assigned by laboratories that
had analysed them until it became impossible to fur-
ther resolve their discrepancies. The last lyophilized
• serum sample was therefore established s CRM 347.
Currently available BCR CRMs for steroid hormone
determination in human serum are:
CRM 192 and CRM 193
for cortisol in human serum
CRM 347 and CRM 348
for progesterone in human serum,
each corresponding to a different concentration of the
hormone (4, 5).
This first example presented the case of a reference
method enabling in principle an assignment of an
unbiased estimate of the "true" value of a well defined
quantity in terms of the amounNof-substance concen-
tration. The second example will address the problem
of the determination of more complex parameters
such s the enzymes. The approach first requires the
selection of the means of expressing the value of the
Parameter. In the case of enzymes it is the catalytic
activity concentration.
The International Federation of Clinical Chemistry
(IFCC) has made a great contribution to the estab-
lishment of recommended methods, in particular in
the field of enzymology. To date, to the best of our
knowledge, three methods have been approved,
namely those for alanine and aspartate aminotrans-
ferase and for creatine kinase. Provisional recommen-
dations have been issued with regard to methods for
γ-glutamyltransferase and alkaline phosphatase. In
each case, the measurement procedure has been care-
fully assessed with regard to possible interferences by
the components of the measurement System. However,
it still appears important to assess the transferability
of the method.
Again, the Community Bureau of Reference organises
interlaboratory studies for this purpose. In particular,
the measurement of alkaline phosphatase was exam-
ined for which a provisional recommendation had
already been issued in 1983 (6). The results obtained
for alkaline phosphatase determination in two suc-
cessive trials are shown in table 1. The number of
laboratories involved in both trials was fourteen. It
must be noted that the samples submitted to the
investigation consisted here of portions of a partially
purified enzyme preparation. This choice was dictated
by the wish to work with a well characterised material,
the method having been previously assessed on serum
samples. Because of the well known problem of reac-
tivation of lyophilized alkaline phosphatase on rehy-
dration, the first sample submitted to the interlabo-
ratory trial was a liquid material. The IFCC-recom-
mended method was used by all participants. How-
ever, some of them admitted that they were not fa-
mili r with it and this resulted in a wider scatter
between laboratories than expected. Another trial was
organised to test, this time, a lyophilized sample for
which a defined protocol for reconstitution was laid
down. In addition, each laboratory carried out further
verifications to ensure the proper functioning of the
Instrumentation used. The result was a net improve-
ment of the consistency of the laboratory sets.
Tab. 1. Determination of the catalytic concentration of alkaline
phosphatase in two consecutive trials, each involving a
different preparation of the partially purified enzyme.
The number of participants was fourteen in each case.
They all followed the IFCC recommended method.
Ist trial
2nd trial
Mean
concentration
bikat/l]
7.69
4.23
Between
laboratory
SD
0.75
0.18
Between
laboratory
CV
9.8
4.3
Figure 5 shows, for each laboratory, the mean value
with 2 Standard deviations, obtained in the first ex-
ercise. Note the considerable within-laboratory Vari-
ation for Lab 11, which had serious problems obtain-
ing reproducible results from day-to-day, and the
large bias of Lab 8. Figure 6 shows the data of the
second exercise, where similar performance was
achieved by all participants with regard to within-
laboratory Variation. Also observe the scale interval,
which was reduced to l μkat/l.
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Fig. 5. Results of an interlaboratory study for the measurement
of alkaline phosphatase catalytic activity, involving
fourteen laboratories using the IFCC method. For each
laboratory? results are expressed s the laboratory mean
value + l SD.
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Fig. 6. Results of the Certification exercise for the measurement
of alkaline phosphatase catalytic activity in CRM 371,
involving fourteen laboratories using the IFCC method.
For each laboratory? results are expressed s the labo-
ratory mean value ± l SD.
As in the case of the serum materials analysed for
steorid hormones, enzyme materials were deemed use-
ful s transfer Standards. Hence the lyophilized prep-
aration of alkaline phosphatase assayed in the second
exercise became CRM 371. The following have been
certified by the BCR:
CRM 319 for γ-glutamyltransferase (7)
CRM 371 for alkaline phosphatase (8)
Conclusions and Future Trends
The development of reference methods is generally
feit to be indispensable, in order to generate repro-
ducible and reliable results. It is increasingly acknowl-
edged that reference methods, assotiated vvhenever
necessary to reference materials, should become an
essential component of a Quality Assurance System.
Therefore the Commission through its Community
Bureau of Reference will support all endeavours to
develop reference method procedures, and to contrib-
ute to their validation. The collaboration established
in the fields of hormonology and enzymology, which
proved to be both efficient and fruitfut, is being
strengthened and will be enlarged to embrace other
branches of clinical chemistry and possibly other areas
of the biomedical analysis.
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